News

ELCC Abstract submission deadline extended to Monday, 9 December 2013!

November 2013

IASLC was built on friendship and will only grow by the support of friendship. Over the next few years we shall take our friendship to a new horizon. The strength of our current membership is broad representation of specialists with targeted interest in prevention, diagnosis, treatment and research in lung cancer. However, we actually have a few members from community oncology practice who deliver direct care to a large portion of lung cancer patients. They look after multiple cancer types, thus will demand more precise and practical information.

Personalized Medicine for Patients with Advanced NSCLC: Perspectives from Asia

SYDNEY - The International Association for the Study of Lung Cancer (IASLC) will host the 15th World Conference on Lung Cancer (WCLC) Oct. 27-30, 2013 in Sydney, Australia. The press conference will be held Monday, Oct. 28 from 12:15 to 1:45 p.m. in the Bayside 101 room inside the Sydney Convention Centre.

SYDNEY – In order to improve prognosis and quality of lung cancer care the Danish Lung Cancer Group has developed a strategy consisting of national clinical guidelines and a clinical quality and research database. In 1998 the first edition of guidelines was published and a registry was opened for registrations in the year 2000. This abstract describes the methods used and the result obtained through the collaborative work and discusses how to improve the quality of lung cancer care through the development and monitoring of indicators.

SYDNEY – In The National Lung Screening Trial reported a 20 percent reduction in lung cancer mortality achieved through low dose computed tomography (CT) screening of the at risk population, compared to screening with chest x-ray. Challenges with clinical implementation of CT screening for lung cancer include the high number of lesions detected that require further follow-up, approximately 97 percent of which are ultimately diagnosed as benign.

Pages